Investment Thesis
Autonomous driving optionality is real but priced in. Margin compression from price cuts, rising competition, and execution risk on robotaxi timeline create asymmetric downside.
Tesla's brand and manufacturing scale remain genuine competitive advantages, but the current valuation requires near-perfect execution on multiple unproven growth vectors simultaneously. The stock prices in successful robotaxi deployment, energy storage hypergrowth, and margin recovery -- any one of which failing to materialize creates significant downside.
Automotive gross margins have compressed from 28% to 17% over the past 18 months as aggressive price cuts failed to sustain volume growth against intensifying Chinese EV competition. Meanwhile, the FSD timeline continues to shift right, with no regulatory approval path visible for unsupervised operation in any major market.
What You're Missing
Our pipeline identified the following contradictions and evidence gaps that most analyses overlook.
Management targets 50% long-term volume CAGR, but trailing twelve-month deliveries grew only 3%. Inventory days have increased from 8 to 28, suggesting demand is not matching production capacity.
Tesla recognizes deferred FSD revenue as features are released, but independent testing shows Level 2 capability at best. The gap between financial recognition and actual autonomous capability creates accounting risk.
Energy segment reported as high-growth with improving margins, but segment-level capex allocation is opaque. Megapack gross margins may be significantly lower than consolidated figures suggest.
No disclosed data on expected per-mile revenue, utilization rates, insurance costs, or regulatory timeline for the Cybercab platform. Valuation models rely entirely on management assumptions.
Limited visibility into competitive dynamics in China as BYD, NIO, and XPeng accelerate model launches. Third-party registration data suggests Tesla's market share has declined from 10% to 7%.
Scenario Analysis
Auto margins fall below 15%. Robotaxi delayed to 2028+. Volume growth stalls at single digits. Multiple compresses to 30x as narrative shifts.
Moderate volume recovery with new models. Margins stabilize at 18%. Energy contributes meaningful growth. FSD progress but no robotaxi launch.
Robotaxi approval in select markets by 2026. Model 2 drives volume re-acceleration. Energy margins surprise to upside. Multiple holds at 60x+.
Key Risks
Gross margins falling below 15% as global EV price war intensifies. Each 1% margin decline reduces EPS by approximately $0.25.
No clear regulatory pathway to unsupervised autonomous operation. Timeline has been pushed back multiple times since 2019.
CEO bandwidth split across Tesla, SpaceX, xAI, and government advisory role. Institutional investor sentiment has deteriorated.
Run your own analysis
Free trial, no credit card required. Get the same depth of analysis for any stock in our 600+ universe.
Start Free Trial →